Sign In
Buy ANIK
$14.41
+0.0300 (+0.209%)
At Close: Jun 03, 2026
Anika Therapeutics Inc (ANIK) Q4 2019 Earnings Call Transcript
03:00am, Friday, 21'st Feb 2020
ANIK earnings call for the period ending December 31, 2019.
Anika Therapeutics, Inc. (ANIK) CEO Cheryl Blanchard on Q4 2019 Results - Earnings Call Transcript
12:56am, Friday, 21'st Feb 2020
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2019 Earnings Conference Call February 20, 2020, 17:00 ET Company Participants Sylvia Cheung - CFO, Treasurer & Se
Anika Therapeutics (ANIK) Beats Q4 Earnings and Revenue Estimates
12:15am, Friday, 21'st Feb 2020
Anika (ANIK) delivered earnings and revenue surprises of 4.88% and 7.75%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Anika Therapeutics (ANIK) Beats Q4 Earnings and Revenue Estimates
12:15am, Friday, 21'st Feb 2020
Anika (ANIK) delivered earnings and revenue surprises of 4.88% and 7.75%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Anika: 4Q Earnings Snapshot
11:11pm, Thursday, 20'th Feb 2020
BEDFORD, Mass. (AP) _ Anika Therapeutics Inc. (ANIK) on Thursday reported fourth-quarter net income of $4.1 million. The Bedford, Massachusetts-based company said it had profit of 28 cents per share.
Anika: 4Q Earnings Snapshot
11:10pm, Thursday, 20'th Feb 2020
BEDFORD, Mass. (AP) _ Anika Therapeutics Inc. (ANIK) on Thursday reported fourth-quarter net income of $4.1 million.
The Bedford, Massachusetts-based company said it had profit of 28 cents per share.
BRIEF-Anika Reports Q4 Earnings Per Share $0.28
09:56pm, Thursday, 20'th Feb 2020
Anika Therapeutics Inc:
Anika Reports Fourth Quarter and Full Year 2019 Financial Results
09:05pm, Thursday, 20'th Feb 2020
Total Revenue Increases 10% Year-over-Year for the Fourth QuarterCompletes Acquisitions of Parcus Medical and ArthrosurfaceCompany Expects Total Revenue Growth in the 40% to 44%.
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
12:06pm, Thursday, 20'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 19) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Akebia
The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA
12:21pm, Wednesday, 19'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) Adverum Biotechnologies Inc (NASDAQ: ADVM ) Anavex
/PRNewswire/ -- The "Viscosupplementation: Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global viscosupplementation...
Global Viscosupplementation Market Overview 2020
12:13pm, Tuesday, 18'th Feb 2020
Dublin, Feb. 18, 2020 -- The "Viscosupplementation: Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global.
Viscosupplementation: Global Market Overview
09:58am, Monday, 17'th Feb 2020
Report Scope: The current report offers a detailed picture of the viscosupplementation market. Viscosupplementation is indicated for the treatment of knee, hip, shoulder and ankle osteoarthritis. Hy
Anika Therapeutics Inc (NASDAQ:ANIK) Receives Average Rating of "Hold" from Analysts
10:00pm, Sunday, 16'th Feb 2020
Anika Therapeutics Inc (NASDAQ:ANIK) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Three research analysts have
The Week Ahead In Biotech: Agile, Baudax Bio, Merck and Esperion Await FDA Decisions
08:03pm, Sunday, 16'th Feb 2020
Biotech stocks were quiet in the week ending Feb. 14 amid some data readouts at a couple of conferences and earnings news flow from smid-cap companies. The following are key biotech catalysts to loo
